Embecta Corp. EMBC
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2022-03-21
Chart by TradingView
6/9
Piotroski F — financial health
1.99
Altman Z″ — distress risk · grey
36.7%
Dividend payout · safe
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $1.1B | $1.1B | $1.1B | $1.1B | $1.2B |
| Gross profit | $676.8M | $735.2M | $749.9M | $774.9M | $800.4M |
| Operating income | $242.1M | $166.8M | $221.5M | $309.6M | $492.0M |
| Net income | $95.4M | $78.3M | $70.4M | $223.6M | $414.8M |
| Operating cash flow | $191.7M | $35.7M | $67.7M | $412.2M | $456.3M |
| Free cash flow | $182.4M | $19.9M | $41.2M | $388.6M | $419.5M |
| Total assets | $1.1B | $1.3B | $1.2B | $1.1B | $788.0M |
| Shareholders' equity | -$650.6M | -$738.3M | -$821.7M | -$891.4M | $594.3M |
| Ratios | |||||
| Gross margin | 62.6% | 65.5% | 66.9% | 68.6% | 68.7% |
| Operating margin | 22.4% | 14.9% | 19.8% | 27.4% | 42.2% |
| Net margin | 8.8% | 7.0% | 6.3% | 19.8% | 35.6% |
| FCF margin | 16.9% | 1.8% | 3.7% | 34.4% | 36.0% |
| Return on assets | 8.7% | 6.1% | 5.8% | 20.6% | 52.6% |
| Return on equity | -14.7% | -10.6% | -8.6% | -25.1% | 69.8% |
| Debt / equity | -2.13× | -2.12× | -1.94× | -1.79× | 0.00× |
| Current ratio | 2.41 | 2.03 | 2.12 | 2.21 | 1.78 |
| Revenue growth | -3.8% | 0.2% | -0.8% | -3.1% | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 144,287 | $1.3M |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 1.99 (grey)
- Working capital / assets 0.339
- Retained earnings / assets -0.408
- EBIT / assets 0.222
- Equity / liabilities -0.374
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001872789 · as of 2025-09-30. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.